Update On Methylphenidate Products Shortage: Clinical Guidance Available

Methylphenidate Products Shortage Update There is a shortage of methylphenidate products affecting Australia. Clinical guidance has been made available for prescribers to help manage prescribing during this shortage. This affects patients who use methylphenidate medications and their healthcare providers.

Product
Clinical guidance for prescribers during the shortages is available.
Reason
Clinical guidance for prescribers during the shortages is available.
Classification
Unclassified
Category
drug recall
Country
Australia
Agency
Therapeutic Goods Administration
Recall date
2025-06-24
Status
Ongoing
Distribution
Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/ef2dc1a5-2fd6-49d8-b1bc-70d50baff443